Related Experiment Video
Updated: Aug 30, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
The molecular mechanisms of cellular tolerance to delta-opioid agonists. A minireview
1Department of Pharmacology, Sarver Heart Center, The University of Arizona, Tucson, Arizona, USA. evarga@email.arizona.edu
Abstract:
Chronic treatment with deltaopioid agonists, similar to other agonist drugs, causes tolerance. Tolerance is a complex adaptation process that consists of multiple, cellular and neural-system adaptations. Cellular tolerance to delta-opioid agonists involves feedback-regulation of the function, concentration, and localization of the delta-opioid receptors (receptor desensitization) as well as of intracellular effectors (functional desensitization). We are using a recombinant Chinese hamster ovary cell line expressing the human delta-opioid receptors (hDOR/CHO) to investigate the molecular mechanisms of cellular tolerance. We found that the structurally distinct delta-opioid agonists mediate receptor down-regulation by different mechanisms. Thus, truncation of the last 35 C-terminal amino acids of the hDOR completely abolished DPDPE, but not SNC 80-mediated receptor down-regulation. In addition, down-regulation of the wild type-, and the truncated hDORs exhibited different inhibitor sensitivity-profile. Chronic delta-opioid agonist treatment also causes functional desensitization of forskolin-stimulated cAMP formation and cAMP overshoot in the hDOR/CHO cells. We have demonstrated that chronic SNC 80 treatment also causes concurrent phosphorylation of the adenylyl cyclase (AC) VI isoenzyme hDOR/CHO cells. Both AC superactivation and AC VI phosphorylation were SNC 80 dose-dependent, naltrindole-sensitive, and exhibited similar time course-, and protein kinase inhibitor-sensitivity profile. We hypothesize that phosphorylation of AC VI plays an important role in delta-opioid agonist-mediated AC superactivation in hDOR/CHO cells.
Insights
Chronic delta-opioid agonist use causes tolerance through cellular adaptations. Distinct agonists trigger different receptor down-regulation pathways, impacting cellular signaling and adenylyl cyclase activity.
Area of Science:
- Pharmacology
- Molecular Biology
- Neuroscience
Background:
- Chronic administration of delta-opioid agonists leads to tolerance, a complex adaptive response involving cellular and neural system changes.
- Cellular tolerance encompasses receptor desensitization (altered function, concentration, localization) and functional desensitization of intracellular effectors.
Purpose of the Study:
- To investigate the molecular mechanisms underlying cellular tolerance to delta-opioid agonists.
- To elucidate the differential effects of structurally distinct agonists on delta-opioid receptor (hDOR) regulation and downstream signaling.
Main Methods:
- Utilized a recombinant Chinese hamster ovary (hDOR/CHO) cell line expressing human delta-opioid receptors.
- Analyzed receptor down-regulation mechanisms in response to different delta-opioid agonists (DPDPE, SNC 80).
- Assessed functional desensitization of forskolin-stimulated cAMP formation and adenylyl cyclase (AC) VI phosphorylation.
Main Results:
- Structurally distinct delta-opioid agonists mediate hDOR down-regulation via different mechanisms; C-terminal truncation affected DPDPE but not SNC 80.
- Down-regulation of wild-type and truncated hDORs exhibited differential inhibitor sensitivity.
- Chronic SNC 80 treatment induced functional desensitization, cAMP overshoot, and concurrent phosphorylation of AC VI, which was dose-dependent and naltrindole-sensitive.
Conclusions:
- Delta-opioid receptor down-regulation pathways are agonist-specific.
- Phosphorylation of adenylyl cyclase VI is implicated in delta-opioid agonist-induced adenylyl cyclase superactivation.
- These findings provide molecular insights into the cellular adaptations driving delta-opioid tolerance.
More Related Videos
07:48Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
Published on: July 3, 2015
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
Related Concept Videos
Analgesia and Pain Management
Opioid Receptors: Overview
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Desensitization and Tachyphylaxis
Several...